Connect with us

Healthcare

Psilocybin’s Antidepressant Effects Can Last Over 12 Months Says New Medical Study

Published

on

Psilocybin’s Antidepressant Effects Are Long Lasting, Says Studies

Millions of people around the world rely on antidepressant medications just to get by.

There are dozens of different antidepressants in the pharmaceutical market, and in order to feel its effects, many need to be taken daily for up to 2 weeks to feel any significant improvements. In addition, these pills can often take from 3 up to 6 months for one to no longer feel depressed, if they even work for you. There are countless people who are unable to rely on the effects of antidepressants because they simply don’t work for them, or make them feel numb; oftentimes, antidepressants can even make you feel worse than you did to start.

The side effects of antidepressants vary: these can include insomnia, fatigue, headaches, diarrhea or constipation, dry mouth, and sexual problems, to name a few. Since depression can truly rob you of quality of life – so either way, it’s a risk.

But what if you only had to take one thing ONCE or twice a year, and notice significant improvements in depression already?

Psilocybin mushrooms may be able to do just that.

A study from earlier this year involved 27 participants, all of whom had a long history with depression. Many were experiencing symptoms of depression for around 2 years before they were recruited for the study, conducted by researchers at Johns Hopkins University, who were following up on previous studies that revealed psilocybin treatment was effective in treating depressive symptoms for up to a month.

Among the participants, 88% were treated with conventional antidepressant medications in the past while 58% said they were using antidepressants currently. After they were all screened, they were divided into two groups randomly, made to attend preparatory meetings, then given two doses of psilocybin 2 weeks apart from August 2017 through April 2019. They also came back to the Johns Hopkins Bayview Medical Center for follow-ups a day and a week after all sessions, followed by follow ups at 1, 3, 6, and 12 month intervals after the 2nd session. Twenty-four of these participants were able to complete all the psilocybin and follow-up visits.

According to the researchers, psilocybin treatment among both groups revealed that there were significant reductions in depression symptoms. The symptoms were also found to stay low for not just one and 3 months, but up to 12 months following treatment.

“Our findings add to evidence that, under carefully controlled conditions, this is a promising therapeutic approach that can lead to significant and durable improvements in depression,” explains Natalie Gukasyan, MD, the Johns Hopkins University School of Medicine assistant professor of psychiatry and behavioral sciences. She does warn that “the results we see are in a research setting and require quit a lot of preparation and structured support from trained clinicians and therapists, and people should not attempt to try it on their own.”

“Psilocybin not only produces significant and immediate effects, it also has a long duration, which suggests that it may be a uniquely useful new treatment for depression,” adds Roland Griffiths, Ph.D., founding director of the Johns Hopkins Center for Psychedelic and Consciousness Research, and a Professor in Neuropsychopharmacology of Consciousness. “Compared to standard antidepressants, which must be taken for long stretches of time, psilocybin has the potential to enduringly relieve the symptoms of depression with one or two treatments.”

Given the track record of standard antidepressants, this is incredible news.

However, the researchers highlight the importance of doing more research to verify that psilocybin is indeed effective enough to last for more than 12 months.

Older Studies

There have been similar older studies done that show similar results.


For one, NYU Grossman School of Medicine researchers followed up on the results of their 2016 study which found that just a one-time treatment of single dose psilocybin was effective in delivering significant improvements for the mental well-being of patients who had cancer.

The cancer patients suffered from existential dread, anxiety, depression, and hopelessness. However, after following up 6.5 months after treatment, they found that psilocybin treatment was associated with better quality of life, improvement in spiritual wellbeing, and decreases in anxiety and depression.

“Our results represent the strongest evidence to date of a clinical benefit from psilocybin therapy, with the potential to transform care for patients with cancer-related psychological distress,” explains Stephen Ross, MD, the study’s lead author. “If larger clinical trials prove successful, then we could ultimately have available a safe, effective, and inexpensive medication – dispensed under strict control – to alleviate the distress that increases suicide rates among cancer patients,” Ross adds.

One of the most important findings of their study was that the clinical scores for depression and anxiety lasted for 8 months – which was far longer than the monitoring period for the study. Study co-author Anthony Bossis, PhD, also said that the patients reported greater improvements in quality of life following psilocybin treatment: they had more energy, went out more, performed better at work, and had better relationships with family members. Some patients even said that they were more spiritual in various ways, experienced unusual peacefulness, and had feelings of altruism.

“Our study showed that psilocybin facilitated experiences that drove reductions in psychological distress,” Bossis said. “And if it’s true for cancer care, then it could apply to other stressful medical conditions.”

Conclusion

Psilocybin is proving to be a remarkable, revolutionary compound in the world of medicine. As of today, it already has found so many far-reaching uses with deep impacts on the lives of people struggling with emotional and mental health. It might not be a panacea, but it is a fantastic starting point that may potentially have long-lasting effects.

Source: https://cannabis.net/blog/medical/psilocybins-antidepressant-effects-can-last-over-12-months-says-new-medical-study

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Business

Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms

Published

on

The Minnesota Supreme Court affirmed that cannabis odor does not constitute probable cause to search a vehicle.

If Minnesota police search a vehicle solely based upon the smell of pot, they can’t justify searching a vehicle, even if there is evidence found of other alleged crimes. Even after appealing a lower court decision to suppress the evidence—twice—the Minnesota Supreme Court agreed, and the dismissal of his charges stands.

In a ruling filed regarding a case the State of Minnesota Court of Appeals on Sept. 13, the Minnesota Supreme Court affirmed that cannabis odor does not constitute probable cause to search a vehicle.

The case has been ongoing for two years. On July 5, 2021, just before 10 p.m., a Litchfield police officer stopped a car for an obscure local law: the light bar mounted on the vehicle’s grill had more auxiliary driving lights than are permitted under Minnesota law. The officer asked the driver, Adam Lloyd Torgerson, for his license and registration. Torgerson, his wife, and his child were present in the vehicle. The officer stated that he smelled pot and asked Torgerson if there was any reason for the odor, which he initially denied. But cops found a lot more than just pot.

A backup officer was called in. The couple denied possessing any pot, but Torgerson admitted to smoking weed in the past. The second officer stated that the weed odor gave them probable cause to search the vehicle and ordered them to exit the vehicle. The first officer searched the vehicle and found a film canister, three pipes, and a small plastic bag in the center console. The plastic bag contained a white powder and the film canister contained meth, which was confirmed in a field test.

Torgenson was charged with possession of meth pipe in the presence of a minor and fifth-degree possession of a controlled substance after the unwarranted search of Torgerson’s vehicle. 

Police Aren’t Allowed to Do That, Multiple Courts Rule

But the search had one major problem—cops weren’t searching for a meth pipe. They only searched his car because they could smell pot, and the meth and paraphernalia were a surprise for everyone. Still, they had no grounds to search the vehicle. The man’s charges were later dismissed after the district court determined the odor of cannabis alone was insufficient basis for probable cause to search the vehicle, regardless of whatever other drug paraphernalia they found. 

The state appealed the case, but the Minnesota Court of Appeals affirmed the district court’s decision. The case was appealed a second time, this time to the Minnesota Supreme Court, which agreed with the lower court’s ruling. 

 “This search was justified only by the odor of marijuana emanating from the vehicle,” the Minnesota Supreme Court decision reads. “Torgerson moved to suppress the evidence found during the search, arguing that the odor of marijuana, alone, is insufficient to create the requisite probable cause to search a vehicle under the automobile exception to the warrant requirement. The district court granted Torgerson’s motion, suppressed the evidence, and dismissed the complaint. The State appealed. The court of appeals affirmed the district court’s suppression order. Because we conclude that the odor of marijuana emanating from a vehicle, alone, is insufficient to create the requisite probable cause to search a vehicle under the automobile exception to the warrant requirement, we affirm.”

It amounts to basic human rights that apply—regardless of whether or not a person is addicted to drugs.

Other States do Precisely the Same Regarding Pot Odor as Probably Cause

An Illinois judge ruled in 2021 that the odor of cannabis is not sufficient grounds for police to search a vehicle without a warrant during a traffic stop.

Daniel J. Dalton, Associate Judge of the 14th Judicial Circuit, issued a ruling in response to a motion to suppress evidence in the case of Vincent Molina, a medical cannabis patient arrested for cannabis possession last year.

In that case, Molina was arrested despite the decriminalization of small amounts of cannabis in Illinois in 2019 with the passage of the Illinois Cannabis Regulation and Tax Act. 

In some states, the issue of probable cause and cannabis was defined through bills.

Last April, the Maryland House of Delegates approved a bill that reduces the penalties for public cannabis consumption and bars police from using the odor of cannabis as the basis for the search of an individual or auto. Under Maryland’s House Bill 1071, law enforcement officers would be prohibited from using the odor of raw or burnt cannabis as probable cause to search a person or vehicle. 

The rulings represent the rights of citizens when they are pulled over by police, even if there are hard drugs involved.

Source: https://hightimes.com/news/pot-odor-does-not-justify-probable-cause-for-vehicle-searches-minnesota-court-affirms/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News